Abliva Overview

  • Founded
  • 2000
Founded
  • Status
  • Public
  • Employees
  • 9
Employees
  • Stock Symbol
  • ABLI
Stock Symbol
  • Investments
  • 2
  • Share Price
  • $0.11
  • (As of Thursday Closing)

Abliva General Information

Description

Abliva AB is a Swedish company which is active in pharmaceutical development. Abliva develops medicines for the treatment of primary mitochondrial diseases. These congenital, rare and often very severe diseases occur when the cell's energy provider, the mitochondria, do not function properly. The portfolio includes projects at different stages and ranges from early discovery phase to clinical phase.

Contact Information

Website
Formerly Known As
NeuroVive Pharmaceutical AB, NeuroVive Pharmaceutical
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Pharmaceuticals
Stock Exchange
STO
Primary Office
  • Medicon Village
  • 223 81 Lund
  • Sweden
+46 046-275 00 00
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Abliva Stock Performance

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.11 $0.11 $0.05 - $0.28 $32.4M 296M 12.7M -$0.05

Abliva Financials Summary

In Thousands,
USD
TTM 30-Jun-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018 FY 2017 31-Dec-2017
EV 26,148 18,505 10,367 14,513
Revenue 16 14 1 3
EBITDA (7,958) (7,889) (8,157) (8,175)
Net Income (8,215) (8,140) (7,858) (7,807)
Total Assets 17,187 15,882 12,828 14,671
Total Debt 0 0 0 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Abliva Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Abliva‘s full profile, request access.

Request a free trial

Abliva Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Abliva AB is a Swedish company which is active in pharmaceutical development. Abliva develops medicines for the treatmen
Pharmaceuticals
Lund, Sweden
9 As of 2020
000.00
000000000 000.00

00000

ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse c
000000000000000
Uppsala, Sweden
000 As of 0000
000.00
0000 0000-00-00
00000000 000.00

00000000

idunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco l
000000000000000
Durham, NC
00 As of 0000
00000
000000 - 000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Abliva Competitors (36)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Orexo Formerly VC-backed Uppsala, Sweden 000 000.00 00000000 000.00
00000000 Formerly VC-backed Durham, NC 00 00000 000000 - 000 00000
000000 00000000000 Formerly VC-backed San Diego, CA 000 00000 000000&0
00000000 Formerly VC-backed Durham, NC 00 00000 000000000 00000
00000000 Corporation Richmond, VA 000 00000 0000 00000
You’re viewing 5 of 36 competitors. Get the full list »

Abliva Executive Team (7)

Name Title Board Seat Contact Info
Erik Kinnman Ph.D Chief Executive Officer
Catharina Johansson Chief Financial Officer & Vice President, Investor Relations & Communications
Magnus Hansson Chief Medical Officer & Vice President, Preclinical and Clinical Development
Eskil Elmér Vice President Discovery & Chief Scientific Officer
You’re viewing 4 of 7 executive team members. Get the full list »

Abliva Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Abliva Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Abliva‘s full profile, request access.

Request a free trial

Abliva Investments & Acquisitions (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000000 00000000 15-Aug-2016 000000000 00.000 Drug Discovery 0000 0000000 00.0
Biotica Technology 11-Mar-2013 Merger/Acquisition Biotechnology
To view Abliva’s complete investments and acquisitions history, request access »